Shanghai Fosun Pharmaceutical

List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape
GoinPharma
Mon, 05/14/18 - 09:32 am
Novartis
dermatology
generics
M&A
Aurobindo
Shanghai Fosun Pharmaceutical
Apollo Global Management